Publication | Open Access
Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin
415
Citations
43
References
2003
Year
Darbepoetin AlfaVivo PotencyHematologyPharmacologyRecombinant Human ErythropoietinMedicine
| Year | Citations | |
|---|---|---|
Page 1
Page 1